- Home
- ANNX vs CPZ Comparison
ANNX vs CPZ Comparison
Compare ANNX & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- CPZ
- Stock Information
- Founded
- ANNX 2011
- CPZ 2019
- Country
- ANNX United States
- CPZ United States
- Employees
- ANNX N/A
- CPZ N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- ANNX Health Care
- CPZ Finance
- Exchange
- ANNX Nasdaq
- CPZ Nasdaq
- Market Cap
- ANNX 334.1M
- CPZ 322.4M
- IPO Year
- ANNX 2020
- CPZ N/A
- Fundamental
- Price
- ANNX $3.00
- CPZ $15.66
- Analyst Decision
- ANNX Strong Buy
- CPZ
- Analyst Count
- ANNX 4
- CPZ 0
- Target Price
- ANNX $13.00
- CPZ N/A
- AVG Volume (30 Days)
- ANNX 2.1M
- CPZ 63.0K
- Earning Date
- ANNX 11-13-2025
- CPZ 01-01-0001
- Dividend Yield
- ANNX N/A
- CPZ 11.07%
- EPS Growth
- ANNX N/A
- CPZ N/A
- EPS
- ANNX N/A
- CPZ N/A
- Revenue
- ANNX N/A
- CPZ N/A
- Revenue This Year
- ANNX N/A
- CPZ N/A
- Revenue Next Year
- ANNX N/A
- CPZ N/A
- P/E Ratio
- ANNX N/A
- CPZ N/A
- Revenue Growth
- ANNX N/A
- CPZ N/A
- 52 Week Low
- ANNX $1.29
- CPZ $13.17
- 52 Week High
- ANNX $7.74
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- ANNX 51.42
- CPZ 35.05
- Support Level
- ANNX $2.87
- CPZ $15.50
- Resistance Level
- ANNX $3.36
- CPZ $16.10
- Average True Range (ATR)
- ANNX 0.21
- CPZ 0.28
- MACD
- ANNX -0.03
- CPZ -0.01
- Stochastic Oscillator
- ANNX 25.24
- CPZ 21.95
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.